126 related articles for article (PubMed ID: 16092001)
1. Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study.
Miller CC; Miller MK; Ghaffari A; Kunimoto B
J Cutan Med Surg; 2004; 8(4):233-8. PubMed ID: 16092001
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections.
Ghaffari A; Jalili R; Ghaffari M; Miller C; Ghahary A
Wound Repair Regen; 2007; 15(3):368-77. PubMed ID: 17537124
[TBL] [Abstract][Full Text] [Related]
3. Potential application of gaseous nitric oxide as a topical antimicrobial agent.
Ghaffari A; Miller CC; McMullin B; Ghahary A
Nitric Oxide; 2006 Feb; 14(1):21-9. PubMed ID: 16188471
[TBL] [Abstract][Full Text] [Related]
4. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers.
Falanga V; Eaglstein WH; Bucalo B; Katz MH; Harris B; Carson P
J Dermatol Surg Oncol; 1992 Jul; 18(7):604-6. PubMed ID: 1624634
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
6. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
Drinkwater SL; Burnand KG; Ding R; Smith A
J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
[TBL] [Abstract][Full Text] [Related]
7. [Questionable effectiveness of autologous platelet growth factors (PDWHF) in treatment of venous ulcers of the leg].
Reutter H; Bort S; Jung MF; Klyscz T; Schippert W; Zuder D; Jünger M
Hautarzt; 1999 Dec; 50(12):859-65. PubMed ID: 10663020
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ovington LG
Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024
[TBL] [Abstract][Full Text] [Related]
9. Gaseous nitric oxide exhibits minimal effect on skin fibroblast extracellular matrix gene expression and immune cell viability.
Moeen Rezakhanlou A; Miller C; McMullin B; Ghaffari A; Garcia R; Ghahary A
Cell Biol Int; 2011 Apr; 35(4):407-15. PubMed ID: 21155711
[TBL] [Abstract][Full Text] [Related]
10. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds.
Jones M; Ganopolsky JG; Labbé A; Gilardino M; Wahl C; Martoni C; Prakash S
Int Wound J; 2012 Jun; 9(3):330-43. PubMed ID: 22221913
[TBL] [Abstract][Full Text] [Related]
11. [A prospective study on wound-healing hydrogel in treating chronic venous ulcer of lower extremities].
He Q; Wu G; Yu B; Zhang T; Wang W; Gu Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):311-3. PubMed ID: 18396709
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.
Tumino G; Masuelli L; Bei R; Simonelli L; Santoro A; Francipane S
Int J Mol Med; 2008 Jul; 22(1):17-23. PubMed ID: 18575771
[TBL] [Abstract][Full Text] [Related]
13. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure.
Miller C; McMullin B; Ghaffari A; Stenzler A; Pick N; Roscoe D; Ghahary A; Road J; Av-Gay Y
Nitric Oxide; 2009 Feb; 20(1):16-23. PubMed ID: 18789393
[TBL] [Abstract][Full Text] [Related]
14. Chronic venous leg ulcers: is topical zinc the answer? A review of the literature.
O'Connor S; Murphy S
Adv Skin Wound Care; 2014 Jan; 27(1):35-44; quiz 45-6. PubMed ID: 24343392
[TBL] [Abstract][Full Text] [Related]
15. Trophic effects of polynucleotides and hyaluronic acid in the healing of venous ulcers of the lower limbs: a clinical study.
De Caridi G; Massara M; Acri I; Zavettieri S; Grande R; Butrico L; de Franciscis S; Serra R
Int Wound J; 2016 Oct; 13(5):754-8. PubMed ID: 25224018
[TBL] [Abstract][Full Text] [Related]
16. Randomized, controlled study of innovative spray formulation containing ozonated oil and α-bisabolol in the topical treatment of chronic venous leg ulcers.
Solovăstru LG; Stîncanu A; De Ascentii A; Capparé G; Mattana P; Vâţă D
Adv Skin Wound Care; 2015 Sep; 28(9):406-9. PubMed ID: 26280699
[TBL] [Abstract][Full Text] [Related]
17. A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds.
Dryden M; Dickinson A; Brooks J; Hudgell L; Saeed K; Cutting KF
J Wound Care; 2016 Mar; 25(3):140, 142-6. PubMed ID: 26947694
[TBL] [Abstract][Full Text] [Related]
18. Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.
Upton Z; Wallace HJ; Shooter GK; van Lonkhuyzen DR; Yeoh-Ellerton S; Rayment EA; Fleming JM; Broszczak D; Queen D; Sibbald RG; Leavesley DI; Stacey MC
Int Wound J; 2011 Oct; 8(5):522-32. PubMed ID: 21914133
[TBL] [Abstract][Full Text] [Related]
19. Silver oxide ointment wound dressing in venous ulcerations: home, self-management.
Belcaro G; Cesarone MR; Errichi BM; Ricci A; Antelman P; Dugall M; Pellegrini L; Ledda A; Viscardi G
Panminerva Med; 2011 Sep; 53(3 Suppl 1):29-33. PubMed ID: 22108474
[TBL] [Abstract][Full Text] [Related]
20. Novel Multivalent Wound-Healing Ointment Provides Bioburden Control and Moisture Management: A Retrospective Registry Data Analysis.
Serena T; Connell H; McConnell S; Patel K; Doner B; Sabo M; Miller M; Serena L; Le LT; Goldsmith D; Chung J
Adv Skin Wound Care; 2016 Oct; 29(10):461-8. PubMed ID: 27632443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
